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Abstract
A high degree of adherence to antiretroviral therapy (ART) in patients infected with human immunodeficiency
virus (HIV) is necessary for long term treatment effects. This study explores the role of timing of ART intake, the
information patients received from health workers, local adherence patterns, barriers to and facilitators of ART
among 28 HIV-positive adults at the Senkatana HIV Clinic in Maseru, Lesotho. This qualitative, semi-structured
interview study was carried out during February and March of 2011 and responses were analyzed inspired by the
Grounded Theory method. Results were then compared and discussed between the authors and the main themes that
emerged were categorized. The majority of the respondents reported having missed one or more doses of medicine in
the past and it was a widespread belief among patients that they were required to skip the dose of ART if they were
“late”. The main barriers to adherence were interruptions of daily routines or leaving the house without sufficient
medicine. The use of mobile phone alarms, phone clocks and support from family and friends were major facilitators
of adherence. None of the patients reported to have been counseled on family support or the use of mobile phones
as helpful methods in maintaining or improving adherence to ART. Being on-time with ART was emphasized during
counseling by health workers. In conclusion, patients should be advised to take the dose as soon as they remember
instead of skipping the dose completely when they are late. Mobile phones and family support could be subjects to
focus on during future counseling particularly with the growing numbers of mobile phones in Africa and the current
focus on telemedicine.
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Background
The prevalence of infections with the human immuno-
deficiency virus (HIV) in Lesotho among adults was
estimated to be 23.1 %, the second highest HIV preva-
lence in the world, with an estimated 15,000 AIDS
related deaths per year in 2012 [1]. Fifty-nine percent of
eligible patients in Lesotho were estimated to receive
antiretroviral therapy (ART) in 2012 [1].
The introduction of ART has changed HIV from a
deadly to a chronic infection for people living with HIV
(PLWH). Research has shown that there is a relation-
ship between the level of adherence to ART and disease
progression [2] and mortality [3]. Current ART can
supress viral load at moderate adherence levels (70–90 %
of prescribed doses taken over a given time), to receive
the best outcomes, however, ART should be taken cor-
rectly as prescribed [4].
Non-adherence increases the risk of development of re-
sistance [5, 6] and since the cost of second-line therapy is
considerably higher than first-line therapy, high levels of
adherence is important for cost control and improved sur-
vival especially in resource-limited countries [7].
Self-reported adherence is the most widely used method
to estimate adherence although it is prone to overestimate
the level of adherence [8]. In a meta-analysis of 27 Sub-
Saharan African studies conducted prior to 2006, 23 % of
the patients receiving ART had sub-optimal levels of
adherence, defined by local thresholds [9]. Sub-optimal
adherence is caused by different barriers to treatment
adherence and frequently reported barriers in Sub-Saharan
Africa include: transport costs [10–12]; lack of social
support (financial and emotional) [13, 14]; service-related
factors [10–14]; pill burden and side-effects [11–14]; poor
knowledge about HIV; stigma [10–12]; non-disclosure of
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HIV status[10, 12, 14]; and a lack of food [12, 14]. Further-
more, adherence tend to decline over time [15–17] and a
major challenge in resource poor settings is yet to provide
ART to all eligible patients [18, 19].
To our knowledge no previous studies have been
conducted exploring the information obtained during
counselling on the timing of ART intake. In more af-
fluent countries, it is suggested that HIV-positive pa-
tients are advised to take their daily ART in
conjuction with daily routines, such as eating dinner
or brushing their teeth [20]. However, it is our per-
sonal experience from clinical work in Lesotho and
Botswana and from discussions with Sub-Saharan Af-
rican colleagues that patients are often told to take
their ART “on time”. “On time” in this setting indicates
to take the daily doses of ART at the exact same time
every day. This practice may cause patients who dis-
cover that they are late, to completely skip the dose.
Thus, the aims of this study was to explore adherence
patterns, describe barriers to and facilitators of adher-
ence to ART, and to investigate the role of “timing of
doses” and information received at the clinic about
“timing of doses”.
Methods
Participants, procedures and settings
The Senkatana HIV clinic had two physicians and three
nurse practitioners employed. The number of patients
visiting the clinic regularly was estimated to be within
the range of 6000–9000 patients. The clinic in Maseru
were in 2011 one of over 30 publicly funded clinics in
the city. The clinic provided counseling, ART and a few
other drugs for free but not travels expenses or nutri-
tional supplements. Prior to initiation of ART, patients
were counseled by adherence counselors (nurse practi-
tioners). Patients were given medication for one month
at a time. For adherence control, patients provided their
remaining medication and an adherence calendar
(“mokoko”) every month to the pharmacists. If patients
had been non-adherent, they were told by the pharma-
cists to take their medicine. The pharmacists referred
patients to a physician for adherence counselling if ne-
cessary. Patients were offered brief counselling during a
follow-up with a physician every 3 months.
PLWH at the Senkatana HIV Clinic in Maseru, Lesotho,
were purposefully selected by non-random sampling as
they were awaiting their monthly clinic visit, during
February and March of 2011. Patients were approached
by the author, T.B., and two local research assistants.
Our sampling goal was to obtain a variety among pa-
tients in terms of gender and age. Eligible patients were
18 years of age and older, HIV-positive and receiving
ART. They were orally informed and gave oral consent
to participation in the study. No financial compensation
was given. It was emphasized that participation was
entirely voluntary, all interviews were confidential and
that whether the patients participated or not would not
affect their treatment at the clinic. A total of 30 patients
were approached for participation, however, two patients
declined to participate. Both gave as reason that they
wished to be financially compensated. The interview-guide
consisted of 17 semi-structured questions and 14 demo-
graphic, structured questions. The author T.B. created the
questionnaire based on his experience with qualitative
research conducted in Denmark among PLWH and on
clinical experience in low-and middle income countries.
Originally written in English, the interview-guide was trans-
lated into the local language Sesotho and double checked
by three independent translators. The set of questions were
constructed to be comprehensive with respect to the rele-
vant themes of adherence in an everyday setting. Each indi-
vidual interview followed its own path and depended on
the patient’s answers. The casual form of the interviews
gave the interviewer the opportunity to ask the informant
to further specify certain answers. Questions regarding ad-
herence were focused on facilitators and barriers to adher-
ence, such as what made it difficult or easy to take the daily
ART. Patients were asked about demographics including
age, gender, and language, names of medicine, duration on
ART, ART regimen, education and monthly household in-
come. Patients were asked whether they had ever missed a
dose of ART and how many days they had missed ART in
the past month and year. Fifteen interviews were carried
out by the senior author, T.B. A local translator was used in
cases where the patient did not speak English. The
remaining 13 interviews were carried out by two local re-
search assistants fluent in both Sesotho and English and
carefully instructed in interviewing techniques. The re-
sponse to each question was written down in English dur-
ing the interview, the phrasing as close to the spoken
words as possible, in a slightly abbreviated form. All inter-
views were discussed with the author, T.B., on the same
day to clarify any misunderstandings and ambiguous an-
swers. The research protocol was approved by the Dir-
ector General of Health Services in Maseru, Lesotho.
Data analysis and management
All handwritten answers were manually converted into
digital forms using Microsoft Words 2010 and grouped
according to specific questions in a Microsoft Excel
2010 spreadsheet by two research assistants and co-
authors, J.M.A. and S.H. All digitized answers were read
and approved as being identical to the original by the
author T.B. The grouped responses were subsequently
analyzed, inspired by the Grounded Theory method
[21], by coding each answer in Microsoft Excel 2010.
Results were then compared and discussed between the
authors and the main themes emerging during the
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coding and analyzing process were categorized. Since
this was a qualitative study and due to the small, non-
random sample size, no statistical analyses were carried
out.
Results
Demographics and ART regimen
Demographic data are presented in Table 1 and ART
regimens in Table 2. Seventeen women and eleven men
were interviewed. Residence was both urban settings in
Maseru, and rural with up to 1 day’s travelling distance to
the clinic. The majority of respondents had some degree of
schooling (89.3 %). A wide range in household income was
seen, with a substantial part of respondents reporting
dependence on a family member’s income. Duration on
ART varied between 2 months and 6 years with a mean of
approximately 3 years, and the majority of patients were on
a once daily (OD) ART regimen with one Nucleoside
Analogue Reverse-Transcriptase Inhibitor (NRTI), one Nu-
cleotide Analogue Reverse-Transcriptase Inhibitor (NtRTI)
and one Non-Nucleoside Reverse-Transcriptase Inhibitor
(NNRTI).
Information received during counseling
The respondents reported that they received adherence
counseling when they initiated ART but no one reported
explicitly having received education, counseling or advice
since then. One patient reported not having received any
counseling since 2004, another patient reported not hav-
ing received any counseling at all and a third patient could
not remember what he was counseled about because he
was very ill at the time.
“I don’t know because I was very ill. Cannot remember
about how and when to take the medicine.” 44-year
old male
The message many patients recalled from their
counseling was to take the medicine at the exact same
time every single day, eat well and keep good hygiene,
not to drink alcohol and the importance of monthly
pill-refills.
“Yes, they told me that I had to take the pill at the
same time and eat well and live in a clean place.”
54-year old female
Patients were informed that alcohol had negative
effects on adherence and health. A couple of patients
mentioned being advised against traditional medicine.
“I was counseled and asked to stop taking traditional
medicine because it would lower CD4 and rise viral
load. Because the virus comes up I will lose weight and
get other diseases.” 24-year old female
Patients were recommended to use the “Mokoko”
(“Mokoko” is the word for rooster in Sesotho), which is
a 1-sheet, 1-month diary with symbols (e.g. a rooster for
the morning, a sun for midday and a moon for evening),
to help remember their doses. The patient can then
check-off every time a dose has been taken on any given
day. It was also used by the clinicians at the monthly
clinic visits for adherence control.
“They told me to mark mokoko at same time every
day. Stop beer and smoke. Stop thinking stress.
Exercise every day.” 49-year old male.
Table 1 Demographic data on respondents (n = 28)
Characteristics Value
Age, mean 39.8 years (range 22–56 years)
Sex 17 females (60.7 %), 11 males (39.3 %)
Years of schooling, mean 6.96 years (10.7 % had no education)
Household income per
month (RSA Rands)a
Mean: 759, Median: 600 (Range: 0–3000)
Number of people per
household
Some are living together with their
siblings, parents or older relatives and
others have their own families with a
partner and typically 1–2 children. A few
patients lived on their own and the main




Mean: 35.9, Median: 36 (Range: 2–72)




aMean income was calculated based on the household’s total reported
income, regardless of whether the patient contributed or the number of
individuals in the household. A few reported no income. Three participants
were excluded, one because the patient had not responded to the question
and two because of uncertainty about the amount of income
Table 2 ART regimen
Drugsa OD BD n = 28 (%)
TDF, 3TC, EFV 12 1 13 (46.4)
TDF, 3TC, NVP 1 4 5 (17.9)
AZT, 3TC, EFV 1 1 (3.6)
AZT, 3TC, rtv/LPV 1 1 (3.6)
D4t, 3TC, EFV 1 1 (3.6)
Cannot remember the name of the drug 6 1 7 (25)
Total 19 9 28 (100)
aNucleoside analog reverse-transcriptase inhibitors (NRTIs): 3TC (Lamivudine), AZT
(Zidovudine), d4T (Stavudine); Nucleotide analog reverse-transcriptase inhibitors
(NtRTIs): TDF (Tenofovir); Non-nucleoside reverse-transcriptase inhibitors (NNRTIs):
EFV (Efavirenz), NVP (Nevirapine); Protease inhibitors (PIs):
rtv/LPV (Ritonavir/Lopinavir)
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It appeared that not all patients knew about their possi-
bility to send friends or family members to refill ART at the
Senkatana HIV clinic.
“We must be allowed to send other people to pick up
med’s. The service is slow…when picking of files [medical
records]. There are three sick-leaves in a month
sometime! Better if all together.” 35-year old female
Missed doses and the role of timing of doses
Patients were asked what they would do if the time of
correct dosing had been surpassed (Table 3). Sixteen out
of 26 (61.5 %) patients (two patients did not respond)
reported that they had missed one or more doses of medi-
cine during their time on ART (mean time on ART:
35.5 months). Only seven patients responded to the specific
questions about how many days they had missed their ART
during the last month (mean: 4.7 days, range: 0–17) and
year (mean: 15.6 days, range: 1–72).
The majority of patients had been advised by clinic staff
to take the medicine either at 7 A.M. or at 7 A.M. and 7
P.M, but a few was informed to choose the time of dosage
on their own.
“How and when [at the pharmacy] to take med’s,
choose time myself, every day, not wait with refill until
finished.” 36-year old male
“Stick to the chosen time and be punctual.” 42-year
old female
One patient explained that she had been told by a
clinician to skip her daily dose, if she was more than
30 minutes late.
“Take them daily at the same hour, not after
30 minutes. Take them for the rest of life.” 29-year old
female
Several patients admitted that they would skip doses
of ART if they came in a situation of being just a few
hours late (Table 3) and two patients had skipped doses
of ART in the past because they were late.
“I stay with my nephews and when they fight I forget
to take the pills. They fight with fists. They were in the
bedroom, I was in the kitchen. I keep the pills in the
bedroom. I am not afraid but forget. I remember later
but was told [by clinic staff] to skip [ART] if too late.”
34-year old female
“Leave it, even if only 1 hour late, and ask counselor.
It happened once when my wife passed away, never
again.” 47-year old male
Barriers to adherence
Barriers to ART-adherence reported by two or more
respondents are shown in Table 4. The reason most
frequently listed by the patients as a barrier to adherence
was a change in routines or an unpredicted event,
which could cause the patient to miss doses for various
time periods, ranging from days to weeks.
“The cows were stolen and I took a week looking for
them and had forgotten the medicine. 15 cows in the
mountains were missing – I walked to get them.” 42-year
old male
“I was stressed because attackers wanted to kill my son
at my home, and I forgot to pick up the medicine. I was
forgetting everything even to eat for at least 3 weeks.









would you skip a
dose
if you were late?
I would skip if I was 1 hour late 1 2
I would skip if I was 3 hours late 2 1
I would skip if I was 4 hours late 4
I would skip if I was 5 hours late 1
I would skip if I was 6 hours late 6 3
I would skip if I was 8 hours late 1
I would skip if I was 12 hours
late
1
I would take it even if 12 hours
late
3 1
I don’t know what to do if I am
late
2
Table 4 Barriers to ART-adherence
Answera n = 28b
Change in routine or an unpredicted event 10
Not bringing pills along when leaving the house 6





Water and/or food were not available 3
Skipping doses of ART as told by clinic staff when
he/she was late
2
aBarriers mentioned by two respondents or more were included in the table
bRespondents were allowed to mention as many options as preferred. Thus
the number of response categories per person to each question could be
higher than one
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Others have already been killed at night with guns, and
animals are stolen.” 47-year old female
Similarly, one woman said she attended a funeral,
another had to take a sick child to the hospital, and a
man was prevented from leaving his job because of a
flood that made medicine unavailable at dose time.
The issue of not bringing pills along when leaving
the house was mentioned as a reason for having
missed one or more doses of medicine.
“I was in a hurry to work. The past 3 months I
have been working in a factory, I get up at five
and meet at seven. I carry [ART] in my pocket,
but sometimes I forget to bring it along with me.”
32-year old male
“I can forget it, if I am busy at work. It happens
sometimes. I am a farmer, and in the morning and in
evening the doses can be missed. I work 2 hours away.
I bring the tablets along if I know I will be busy… but
sometimes I did not know I would be busy, or I was
travelling, and there was no water. I cannot take it
without water.” 52-year old male
“I am a driver. They can ask me to go to RSA or other
countries and not sleep at home. Sometimes I could
not take [ART].” 43-year old male
Another problem was running out of pills or being
prevented from picking up refills. In some cases the
reason for why a patient had not managed to refill in time
was simply forgetfulness. Others mentioned being out of
town or unable to pick up refills. In the following example
the patient arrived late at the clinic and could not refill
her pill bottle because the clinic was closed for the day.
“This last Friday I came after 12 [A.M.] and the
reception was closed. The people were there but did not
want to unlock. I was late because I had problems with
the taxi. I have been told to be here at 11, but the taxi
broke on the way. I missed [taking ART] Sunday through
Monday and Tuesday morning.” 46-year old female
Alcohol was a barrier mentioned by a few patients.
One patient explained that he would skip his medicine
when he had been drinking due to concerns about
interactions with alcohol. Another patient missed sev-
eral doses due to forgetfulness caused by alcohol.
“Yes, I was drinking beer, and was forgetting an entire
week. Then I was taken to the counselor by the
grandmother. It happened for only 1 week.” 25-year old
male
Work (meetings, long and busy working days or
advice to take ART during working hours) would cause
patients to postpone or miss one or more doses of ART.
“Once I postponed for three hours because I was in a
meeting.” 42-year old female
Another barrier to adherence was that water and/or
food were not available when it was time to take the
medicine. Some patients felt that the medicine made
them hungry and when food was not available they
would skip a dose. Another patient would not be able to
swallow the pills without water.
“I was not forgetting but I defaulted because I had
nothing to eat, and pills make me hungrier.” 33-year
old female
“I missed a dose of medicine 2 weeks ago. I was on a
journey, and I had no water, but I had the tablets in
my pocket.” 52-year old male
Two patients reported skipping doses of ART as told
by clinic staff when he/she was late with a dose. (See
citations in Missed Doses and the role of Timing of Doses.)
A few reported that they missed daily doses of medi-
cine because they simply forgot or slept over and one
patient explained that the night-dose in a bi-daily (BD)
ART regimen was the most difficult to remember.
Facilitators of adherence
The facilitators of ART-adherence reported by two or
more respondents are shown in Table 5. A large num-
ber of respondents listed the mobile phone alarm
and/or mobile phone clock as the primary tool to
help remember taking ART. Not all patients had a
mobile phone of their own, but most households had
access to one. The mobile phone often belonged to a
younger family member.
“I am reminded by my husband and by our phone
alarm. The alarm rings at seven when I take it, and
eight, when he takes it.” 36-year old female
“My children say:” Daddy it is time to take the
medicine” when they hear the phone alarm.”
43-year old male
Support from family and/or friends was a frequently
reported facilitator of ART-adherence.
“My sister reminds me, we live together, she is HIV-
unknown, but looks sick. Puts them [the pills] where I
can see them.” 33-year old female
Axelsson et al. Journal of Health, Population and Nutrition  (2015) 33:10 Page 5 of 9
“My children. They made a song called Sogum [the
medicine] – “Mummy it is time for Sogum”.” 45-year
old female
“Wife or children [remind him] if phone battery is
charged far away from home.” 44-year old male
TV and radio or using a regular clock or alarm clock
also played a dominant role in helping patients remember
to take the medicine on time.
“Radio. I am a babysitter, listens all the time.” 39-year
old female
“Radio. I do not know how to read the clock.” 32-year
old female
“Watch, no alarm, or TV. I have no cell phone.” 22-year
old female
“Looks at the clock on the wall. If not home – I have
another watch. Have no cell phone. Takes it after meal
or if no food just takes them.” 56-year old female
Another facilitator of adherence was to have an HIV-
positive partner, relative or friend to share the experi-
ence with or get reminders and support from.
“My wife reminds me, she is also on ARV’s, also takes
them seven, but BD.” 41-year old male
“My neighbor, who is also positive – asks: “now it is 7
o’clock, did you take it?”.” 39-years old female
Several patients stated that they would remember their
medication spontaneously. Three patients mentioned
previously severe symptoms of HIV infection, which
motivated them to stay adherent to ART. After initiating
ART one patient began to feel better and explained:
“I have the interest in taking them [the pills] because I
was very sick and got better after taking them.” 47-year
old female
Two patients used the mokoko to remember their
daily doses of ART and two other patients were plan-
ning ahead, typically by bringing ART along when leav-
ing the house. For example a 36-year old male always
made sure he was home when it was time to take the 7
P.M. dose and he would bring ART along on travels.
Two respondents reported predominantly positive
emotions and feed-back when they disclosed their HIV
serostatus to family members and co-workers.
“It helps that I have disclosed to boss and all co-workers.”
32-year old male
Discussion
In this qualitative study we discovered “surpassed medica-
tion intake time” as an issue, and mapped obstacles and
facilitators of adherence to treatment. A change in routine,
an unpredicted event or leaving home without pills was
often mentioned as obstacles to ART-adherence. Use of
mobile phones and social support appear to be key factors
in ensuring adherence to ART.
The non-randomly selected group of adult respondents
had a majority of women and an education level slightly
higher than the overall estimated mean years of schooling
in Lesotho, (6.9 vs. 5.9 years (2012)) [22], in congruence
with the higher HIV prevalence in women [23], the slightly
higher prevalence of women in Lesotho and the urban–
rural disparities in school attendance [24].
The interviews indicated that the patients did not receive
adherence counseling as frequently as would be optimal. It
is known that adherence is not static, but is a dynamic
process and tends to decline over time [15–17]. Increasing
the frequency of education and counseling could therefore
be an area of intervention to improve adherence in this set-
ting, as shown in earlier Sub-Saharan studies [25].
We found that the respondents were generally told by
the counselors to take their medication “on time” and
unfortunately, several patients were willing to skip their
medication, if they discovered they were late by just a few
hours. Two patients were skipping doses of ART as told
by clinic staff when he/she was late. This iatrogenic
Table 5 Facilitators of ART-adherence
Answera n = 28b
Mobile phone alarm and/or mobile phone clock 18
Support from family and/or friends 17
TV and Radio 12
Regular clock or alarm clock 9
HIV-positive partner, relative or friend 7
Remember the medication pontaneously 5
Previous severe symptoms of HIV infection 3
Mokokoc 2
Planning ahead 2
Disclosure of HIV serostatus 2
aFacilitators mentioned by two respondents or more were included in the table
bRespondents were allowed to state/mention as many options as preferred.
Thus the number of response categories per person to each question could be
higher than one
cMokoko (meaning “rooster” in Sesotho), is a markable 1-sheet 1-month calendar
built up by symbols (e.g. A rooster for the morning, a sun for the day and a moon
for the evening) to help patients remember their doses
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barrier has to our knowledge not been explored elsewhere,
although it has been reported as a barrier to ART adher-
ence by a health care provider and three patients who
were failing second-line ART in a small study from RSA
[26]. In more affluent countries, forgetfulness has shown
to be an important barrier to ART adherence and it has
been suggested to advice patients to link the daily dosage
with a daily routine such as tooth brushing or having
breakfast [20]. However, patients reported that inconsist-
ency in daily routines was a primary barrier to adherence.
Therefore, coupling medication intake with daily routines
may be sub-optimal in this setting. There are no large ran-
domized controlled trials which compare regimens of “on
time” with “routine coupled” dosage of ART in Sub-
Saharan Africa. In a small pilot study viral suppression was
maintained at 24 and 48 weeks on intermittent treatment
with an Efavirenz-based regimen (5 days on and 2 days off)
[27]. In contrast, studies of longer (≥1 week) ART interrup-
tions have resulted in increased viral load [28, 29]. We sug-
gest that physicians should emphasize to patients the
importance of taking a delayed dose as soon as they re-
member, instead of skipping the dose completely.
The main barriers to adherence in this study were related
to hassles of daily life, such as a change in routine or an
unpredicted event. Not bringing pills along when leav-
ing the house was also a frequently mentioned barrier.
Other researchers have reported being away from medicine
at dose time as the main reasons for non-adherence [30].
Patients should be advised to maintain a travel kit filled
with sufficient medication for the duration of their absence
from home. Pill burden was not reported as a barrier to
ART adherence in this setting but one patient found the
night dose in a BD regimen as more difficult to remember
than the morning dose. The majority of patients were on a
OD ART regimen which could improve adherence as op-
posed to BD regimens [31].
A few patients had skipped doses of ART because
water and/or food were not available at dose time.
Lack of food [12, 14] and hunger [30, 32–34] have
previously been reported as barriers to adherence to
ART in sub-Saharan Africa. Cantrell et al. conducted a
pilot study in Zambia, showing improved adherence
with food supplements delivered to HIV patients on
ART [35]. Other solutions could be to advice patients
to always carry a bottle of water and a snack together
with the daily ART. Alcohol is a problem in Sub-
Saharan Africa, especially with its unfortunate effects
on HIV transmission rates and ART adherence [36]. In
our sample of patients, alcohol was reported as a barrier
to ART adherence by four patients. The majority of pa-
tients recalled being counselled not to drink alcohol. Some
patients were running out of pills or being prevented
from picking up refills. At the Senkatana HIV clinic in
Lesotho it is an option to send friends or family members
to pick up ART at the clinic, but this was not known to all
of the respondents.
In this study the mobile phone alarm and/or mobile
phone clock was often used by patients or their friends
and family as medication reminders. A recent qualitative
study from Ethiopia report the same use of mobile phones
as a reminder tool [37]. Other studies have found posi-
tive evidence with supportive text messages and other
reminder devices [25, 38, 39]. At the clinic in Maseru,
reminding patients by sending text messages was not
an option at the time of the study. With an estimated
86.3 mobile-phone subscriptions per 100 inhabitants in
Lesotho in 2013 [40] and the growing number of mobile
phones in Africa [41–43], this practice could face wide-
spread application. Most respondents had access to a
mobile phone in this setting and thus, using Short Mes-
sage Service in ART-clinics could be a future option. Sup-
port from family and/or friends facilitated adherence,
for example the children of the person taking ART. The
literature suggests school education programs for children
to strengthen their role as treatment supporters [38].
Recommending patients to bring family members along to
counseling and to treat family members together has
shown to have a positive impact on adherence [15]. We
saw a tendency to form alliances with an HIV-positive
partner, relative or friend and peer-counseling has been
shown to have a positive effect on adherence [44]. Several
patients in this setting used the TV or radio as a reminder
and other studies confirm this method’s frequent use [38].
We suggest that clinicians discuss with the patient the
preferred facilitators, and encourage its use.
One of the major obstacles to improvement of HIV/
AIDS health care in Sub-Saharan Africa is to ensure that
all patients eligible for ART have access to ART. In 2012
an estimated 59 % of all eligible patients received ART
in Lesotho [1]. Once ART is initiated an estimated 72 %
of the patients in Lesotho are still on ART 12 months
after commencement [1]. Thus retention to ART and ac-
cessibility are important issues to address. Addressing
these issues may have a greater impact on survival than
simply focusing on individual adherence.
To address these major challenges we suggest: introdu-
cing more flexible refill-practices, telling patients that fam-
ily members are allowed to pick up medicine, introducing
rations that last for more than a month, group sessions to
encourage peer-support, more frequent counseling includ-
ing education about disease and treatment, and sending
text messages in advance to remind patients that it is time
for a refill. Actions costing money like additional counsel-
ing sessions or text message services may not be realistic
to implement in HIV-clinics of recourse limited countries.
However, the existing counseling may be improved con-
cerning the information given. Adherence and quality of
life may be improved by allowing the patients to be more
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flexible with regard to timing of doses, for instance by tak-
ing the medicine in combination with a daily routine or to
take the dose as soon as they remember instead of skip-
ping it completely if they are delayed, and informing the
patients about the potentials of mobile phones and sup-
port from family and friends. Specifically, counselors could
focus on the scenario of an upcoming unexpected event
or a change in routines and how to prepare patients for
these situations. Finally we believe that it is of great im-
portance that counselors are attentive towards patients’
preferred methods of remembering their ART doses and
try to facilitate their good behavior.
Strengths and limitations
A strength of this study is that we explored in depth the
barriers and facilitators, and that the issue of “surpassed
medication intake time” was discovered. The in-depth
interviews in native language enhance trustworthiness of
the findings. However, there are also some limitations to
our study. The relatively few respondents, the fact the
researchers did not speak the local language, and the
lack of taped interviews. Another limitation to our study
is that only patients were interviewed in depth. It would
have been optimal to be able to compare patients’ and
clinicians’ point of views. Finally, the findings of this
study cannot necessarily be generalized to other coun-
tries or parts of Lesotho due to the small, non-randomly
design. However, the issues of timing of doses of ART
and the widespread use of mobile phones may well be
useful in other Sub-Saharan African HIV clinics. This
study confirms the complexity of barriers to and facilita-
tors of adherence to ART.
Conclusions
Our findings suggest that patients are often told by clini-
cians to be strictly on time with their doses of ART and
unfortunately several patients would skip a dose if they
came in a situation of being only a few hours late. Patients
should be advised to take their medicine immediately
when they remember, instead of skipping it altogether
when late. We hypothesize, that in some settings it may
be easier for patients to be adherent to ART if the
medication is linked to daily routines, for example
tooth-brushing, but the literature lacks large random-
ized clinical trials comparing medication intake at
exactly the same time each day with medication intake
linked to daily routines. A major barrier to ART adherence
was interruptions of daily routines and therefore coupling
medication intake to daily routines may be unsuitable in
this setting. Leaving the house without sufficient medicine
was also listed as an important barrier and patients should
be advised to maintain a travel kit. Mobile phone alarms
and family support were major facilitators of adherence
and is supported in the literature. None of the patients
reported to have been counseled on family support or the
use of mobile phones as helpful methods to improve ad-
herence to ART. These areas could be subjects of focus
during counseling particularly with the growing numbers
of mobile phones in Africa and the current focus on
telemedicine.
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